ESC 365 - CETP inhibition: lessons from two decades of clinical trials

Open Access

CETP inhibition: lessons from two decades of clinical trials

Session: Innovating the clinical management of LDL-c: exploring CETP as therapeutic target

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor S. Nicholls (Melbourne, AU)

Sponsored by PACE-CME - Supported by an unrestricted educational grant from NewAmsterdam Pharma & Menarini

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

53 presentations

5 followers

4 more presentations in this session

Introduction

Speaker: Professor K. Ray (London, GB)

What do we know now that could have changed the history of CETP Inhibition? Genetics and biology

Speaker: Professor J. Kastelein (Amsterdam, NL)

A novel CETP-inhibitor to target CV risk reduction: where could it fit in future lipid management?

Speaker: Professor E. Michos (Baltimore, US)

Discussion

Speaker: Professor K. Ray (London, GB) Professor G. Norata (Milan, IT)

Access the full session

Innovating the clinical management of LDL-c: exploring CETP as therapeutic target

Speakers: Professor S. Nicholls, Professor K. Ray, Professor J. Kastelein, Professor E. Michos, Professor K. Ray...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources